You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 20, 2024

ESCLIM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Esclim patents expire, and when can generic versions of Esclim launch?

Esclim is a drug marketed by Women First Hlthcare and is included in one NDA.

The generic ingredient in ESCLIM is estradiol. There are seventy-five drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the estradiol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Esclim

A generic version of ESCLIM was approved as estradiol by BARR LABS INC on October 22nd, 1997.

  Try a Trial

US Patents and Regulatory Information for ESCLIM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-001 Aug 4, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-004 Aug 4, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-002 Aug 4, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-003 Aug 4, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-005 Aug 4, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ESCLIM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-003 Aug 4, 1998 ⤷  Try a Trial ⤷  Try a Trial
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-001 Aug 4, 1998 ⤷  Try a Trial ⤷  Try a Trial
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-005 Aug 4, 1998 ⤷  Try a Trial ⤷  Try a Trial
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-004 Aug 4, 1998 ⤷  Try a Trial ⤷  Try a Trial
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-002 Aug 4, 1998 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ESCLIM

See the table below for patents covering ESCLIM around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 0288336 SELF-STICKING DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF AN ACTIVE AGENT ⤷  Try a Trial
Austria 69724 ⤷  Try a Trial
Greece 3003887 ⤷  Try a Trial
France 2612785 ⤷  Try a Trial
Japan H0780758 ⤷  Try a Trial
Portugal 87029 PROCESSO PARA A PREPARACAO DE UM DISPOSITIVO AUTO-ADESIVO PARA ADMINISTRACAO DE UM PRINCIPIO ACTIVO POR VIA PERCUTANEA ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ESCLIM

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1453521 15C0050 France ⤷  Try a Trial PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129
1214076 SZ 49/2008 Austria ⤷  Try a Trial PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON
0136011 99C0003 Belgium ⤷  Try a Trial PRODUCT NAME: ESTRADIOL AND NORETHISTERONE; FIRST REGISTRATION NO/DATE: 403 IS 106 F3 19980928; FIRST REGISTRATION: SE 14007 19980306
0770388 PA2009004,C0770388 Lithuania ⤷  Try a Trial PRODUCT NAME: ESTRADIOLI VALERAS + DIENOGESTUM; NAT. REGISTRATION NO/DATE: LT/1/09/1512/001, 2009 04 06 LT/1/09/1512/002, 2009 04 06 LT/1/09/1512/003 20090406; FIRST REGISTRATION: BE 327792 20081103
0771217 CA 2006 00038 Denmark ⤷  Try a Trial PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804
2782584 122021000080 Germany ⤷  Try a Trial PRODUCT NAME: ZUSAMMENSETZUNG, DIE SOWOHL ESTRADIOL (17SS-ESTRADIOL), GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, HYDRATS ODER SOLVATS DAVON (EINSCHLIESSLICH IN FORM EINES HEMIHYDRATS), ALS AUCH PROGESTERON ENTHAELT; NAT. REGISTRATION NO/DATE: 2205034.00.00 20210924; FIRST REGISTRATION: BELGIEN BE582231 20210406
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.